ESPERION THERAPEUTICS INC. - COMMON STOCK

Esperion to Participate in Upcoming September Investor Conferences

26 Aug 2025 05:00:01 By Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

07 Aug 2025 14:30:00 By Nasdaq GlobeNewswire

Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update

05 Aug 2025 03:00:00 By Nasdaq GlobeNewswire

Esperion to Report Second Quarter 2025 Financial Results on August 5

22 Jul 2025 05:00:00 By Nasdaq GlobeNewswire

Esperion Reaches Settlement Agreement with Third ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040

08 Jul 2025 05:00:01 By Nasdaq GlobeNewswire

Esperion Appoints Craig Thompson to Board of Directors

01 Jul 2025 05:06:21 By Nasdaq GlobeNewswire

Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040

02 Jun 2025 05:00:00 By Nasdaq GlobeNewswire

Esperion to Participate in Upcoming June Investor Conferences

20 May 2025 05:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

15 May 2025 06:49:04 By NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

14 May 2025 07:46:17 By NetDania Notify

Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040

12 May 2025 05:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

09 May 2025 08:42:13 By NetDania Notify

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference

09 May 2025 05:00:01 By Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 May 2025 13:30:00 By Nasdaq GlobeNewswire

Esperion Partners with HLS Therapeutics to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Canada

08 May 2025 03:30:00 By Nasdaq GlobeNewswire

Esperion Reports First Quarter 2025 Financial Results

06 May 2025 03:00:00 By Nasdaq GlobeNewswire

Esperion to Participate in The Citizens Life Sciences Conference

25 Apr 2025 05:00:00 By Nasdaq GlobeNewswire

Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025

24 Apr 2025 05:00:01 By Nasdaq GlobeNewswire

Esperion to Report First Quarter 2025 Financial Results on May 6

23 Apr 2025 05:00:01 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

21 Apr 2025 06:45:19 By NetDania Notify